Beijing Sun-Novo Pharmaceutical Research Dividende
Dividende contrôle des critères 2/6
Beijing Sun-Novo Pharmaceutical Research is a dividend paying company with a current yield of 0.36% that is well covered by earnings.
Informations clés
0.4%
Rendement du dividende
n/a
Rendement des rachats
| Rendement total pour l'actionnaire | n/a |
| Rendement futur des dividendes | 2.7% |
| Croissance des dividendes | n/a |
| Prochaine date de paiement du dividende | n/a |
| Date ex-dividende | n/a |
| Dividende par action | CN¥0.165 |
| Ratio de distribution | 8% |
Mises à jour récentes des dividendes
Pas de mise à jour
Recent updates
Investors Still Aren't Entirely Convinced By Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s (SHSE:688621) Earnings Despite 40% Price Jump
Oct 02
Concerns Surrounding Beijing Sun-Novo Pharmaceutical Research's (SHSE:688621) Performance
Sep 05Market Still Lacking Some Conviction On Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHSE:688621)
Jul 31We Think Beijing Sun-Novo Pharmaceutical Research (SHSE:688621) Can Stay On Top Of Its Debt
May 29Stabilité et croissance des paiements
Récupération des données sur les dividendes
Dividende stable: 688621 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Dividende croissant: 688621 has only been paying a dividend for 3 years, and since then payments have fallen.
Rendement des dividendes par rapport au marché
| Beijing Sun-Novo Pharmaceutical Research Rendement des dividendes par rapport au marché |
|---|
| Segment | Rendement du dividende |
|---|---|
| Entreprise (688621) | 0.4% |
| 25% du marché (CN) | 0.6% |
| 25% du marché (CN) | 2.2% |
| Moyenne du secteur (Life Sciences) | 1.2% |
| Analyste prévisionnel (688621) (jusqu'à 3 ans) | 2.7% |
Dividende notable: 688621's dividend (0.36%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.57%).
Dividende élevé: 688621's dividend (0.36%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
Bénéfice distribué aux actionnaires
Couverture des revenus: With its low payout ratio (8.4%), 688621's dividend payments are thoroughly covered by earnings.
Paiement en espèces aux actionnaires
Couverture des flux de trésorerie: With its low cash payout ratio (14.6%), 688621's dividend payments are thoroughly covered by cash flows.